Global Multiplex Biomarker Imaging
Global Multiplex Biomarker Imaging

Multiplex Biomarker Imaging Comprehensive Study by Type (Immunohistochemistry (IHC) Assay, Fluorescent In Situ, Hybridization (FISH) Assay, Tissue Microarray (TMA) Assay), Application (Oncology Studies, Drug Safety, Genetic Characterization, Others), Components (Kits, Instruments, Software, Other), End User (Research Institutes, Translational Lab, Pharma & Biopharma Companies, Hospitals, Others) Players and Region - Global Market Outlook to 2026

Multiplex Biomarker Imaging Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 232 Pages 195 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Multiplex Biomarker Imaging Market Overview:
Multiplex Biomarker Imaging is used to extract more and accurate information about the diseased tissues. Multiplexed staining approaches are expected to increase the amount of information that can be obtained from intact tumor anatomy as well as to delineate the spatial and temporal expression information. Multiplexed biomarker imaging can help expose the spatial associations between stromal and immune cells within tumors, allowing for more detailed characterization. Due to multiplexed biomarkers, with just tiny sample material, researchers can get detailed information quickly.

Growth Drivers
  • Need of Rapid Precision Profiling in Tumour Biology
  • Need to Visualize Multiple Biomarkers

Market Trends
  • Growing Research in The Multiplex Biomarker Imaging for More Accurate and Rapid Results

Roadblocks
  • Complex Nature of Biomarker Validation Hindering Multiplex Biomarker Imaging

Opportunities
  • Increasing Investment in Cancer Treatment Will Boost the Demand of Multiplex Biomarker Imaging
  • Rapid Commercialization of Multiplex Biomarker Imaging Technology Will Increase Its Demand

Challenges
  • High Cost Associated with Multiplex Biomarker Imaging


Competitive Landscape:

Some of the key players profiled in the report are Bio-Rad Laboratories, Inc. (United States), Ultivue Inc. (United States), Luminex Corporation (United States), Merck KGaA (Germany), BioTek Instruments, Inc (United States), Akoya Biosciences (United States), BioreclamationIVT. ELEVATING SCIENCE (United States), Applied Micro Arrays (United States), Pacific Biomarkers (United States) and PerkinElmer Inc (United States). Considering Market by Components, the sub-segment i.e. Kits will boost the Multiplex Biomarker Imaging market. Considering Market by End User, the sub-segment i.e. Research Institutes will boost the Multiplex Biomarker Imaging market.

Latest Market Insights:
On 9th April 2020, Bio-Rad Laboratories, Inc., leader of life science research and clinical diagnostic products, announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the acquisition in more detail during its first-quarter 2020 financial results conference call.

On 9th Nov 2017, Ultivue announced the commercial launch of InSituPlex Services, which provides transformative tissue interrogation of protein biomarker expression patterns. The service is based on the company's patented InSituPlex technology, which allows for impartial biomarker analysis in tissue at the high multiplex and spatial resolution.

What Can be Explored with the Multiplex Biomarker Imaging Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Multiplex Biomarker Imaging Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Multiplex Biomarker Imaging
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Multiplex Biomarker Imaging market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Multiplex Biomarker Imaging market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Multiplex Biomarker Imaging Providers, Suppliers and Distributors, Government Regulatory and Research Organizations, End-Use Industries and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Immunohistochemistry (IHC) Assay
  • Fluorescent In Situ
  • Hybridization (FISH) Assay
  • Tissue Microarray (TMA) Assay
By Application
  • Oncology Studies
  • Drug Safety
  • Genetic Characterization
  • Others
By Components
  • Kits
  • Instruments
  • Software
  • Other

By End User
  • Research Institutes
  • Translational Lab
  • Pharma & Biopharma Companies
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Need of Rapid Precision Profiling in Tumour Biology
      • 3.2.2. Need to Visualize Multiple Biomarkers
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated with Multiplex Biomarker Imaging
    • 3.4. Market Trends
      • 3.4.1. Growing Research in The Multiplex Biomarker Imaging for More Accurate and Rapid Results
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Multiplex Biomarker Imaging, by Type, Application, Components, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Multiplex Biomarker Imaging (Value)
      • 5.2.1. Global Multiplex Biomarker Imaging by: Type (Value)
        • 5.2.1.1. Immunohistochemistry (IHC) Assay
        • 5.2.1.2. Fluorescent In Situ
        • 5.2.1.3. Hybridization (FISH) Assay
        • 5.2.1.4. Tissue Microarray (TMA) Assay
      • 5.2.2. Global Multiplex Biomarker Imaging by: Application (Value)
        • 5.2.2.1. Oncology Studies
        • 5.2.2.2. Drug Safety
        • 5.2.2.3. Genetic Characterization
        • 5.2.2.4. Others
      • 5.2.3. Global Multiplex Biomarker Imaging by: Components (Value)
        • 5.2.3.1. Kits
        • 5.2.3.2. Instruments
        • 5.2.3.3. Software
        • 5.2.3.4. Other
      • 5.2.4. Global Multiplex Biomarker Imaging by: End User (Value)
        • 5.2.4.1. Research Institutes
        • 5.2.4.2. Translational Lab
        • 5.2.4.3. Pharma & Biopharma Companies
        • 5.2.4.4. Hospitals
        • 5.2.4.5. Others
      • 5.2.5. Global Multiplex Biomarker Imaging Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Multiplex Biomarker Imaging: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ultivue Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Luminex Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck KGaA (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioTek Instruments, Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Akoya Biosciences (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioreclamationIVT. ELEVATING SCIENCE (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Applied Micro Arrays (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pacific Biomarkers (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PerkinElmer Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Multiplex Biomarker Imaging Sale, by Type, Application, Components, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Multiplex Biomarker Imaging (Value)
      • 7.2.1. Global Multiplex Biomarker Imaging by: Type (Value)
        • 7.2.1.1. Immunohistochemistry (IHC) Assay
        • 7.2.1.2. Fluorescent In Situ
        • 7.2.1.3. Hybridization (FISH) Assay
        • 7.2.1.4. Tissue Microarray (TMA) Assay
      • 7.2.2. Global Multiplex Biomarker Imaging by: Application (Value)
        • 7.2.2.1. Oncology Studies
        • 7.2.2.2. Drug Safety
        • 7.2.2.3. Genetic Characterization
        • 7.2.2.4. Others
      • 7.2.3. Global Multiplex Biomarker Imaging by: Components (Value)
        • 7.2.3.1. Kits
        • 7.2.3.2. Instruments
        • 7.2.3.3. Software
        • 7.2.3.4. Other
      • 7.2.4. Global Multiplex Biomarker Imaging by: End User (Value)
        • 7.2.4.1. Research Institutes
        • 7.2.4.2. Translational Lab
        • 7.2.4.3. Pharma & Biopharma Companies
        • 7.2.4.4. Hospitals
        • 7.2.4.5. Others
      • 7.2.5. Global Multiplex Biomarker Imaging Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Multiplex Biomarker Imaging: by Type(USD Million)
  • Table 2. Multiplex Biomarker Imaging Immunohistochemistry (IHC) Assay , by Region USD Million (2015-2020)
  • Table 3. Multiplex Biomarker Imaging Fluorescent In Situ , by Region USD Million (2015-2020)
  • Table 4. Multiplex Biomarker Imaging Hybridization (FISH) Assay , by Region USD Million (2015-2020)
  • Table 5. Multiplex Biomarker Imaging Tissue Microarray (TMA) Assay , by Region USD Million (2015-2020)
  • Table 6. Multiplex Biomarker Imaging: by Application(USD Million)
  • Table 7. Multiplex Biomarker Imaging Oncology Studies , by Region USD Million (2015-2020)
  • Table 8. Multiplex Biomarker Imaging Drug Safety , by Region USD Million (2015-2020)
  • Table 9. Multiplex Biomarker Imaging Genetic Characterization , by Region USD Million (2015-2020)
  • Table 10. Multiplex Biomarker Imaging Others , by Region USD Million (2015-2020)
  • Table 11. Multiplex Biomarker Imaging: by Components(USD Million)
  • Table 12. Multiplex Biomarker Imaging Kits , by Region USD Million (2015-2020)
  • Table 13. Multiplex Biomarker Imaging Instruments , by Region USD Million (2015-2020)
  • Table 14. Multiplex Biomarker Imaging Software , by Region USD Million (2015-2020)
  • Table 15. Multiplex Biomarker Imaging Other , by Region USD Million (2015-2020)
  • Table 16. Multiplex Biomarker Imaging: by End User(USD Million)
  • Table 17. Multiplex Biomarker Imaging Research Institutes , by Region USD Million (2015-2020)
  • Table 18. Multiplex Biomarker Imaging Translational Lab , by Region USD Million (2015-2020)
  • Table 19. Multiplex Biomarker Imaging Pharma & Biopharma Companies , by Region USD Million (2015-2020)
  • Table 20. Multiplex Biomarker Imaging Hospitals , by Region USD Million (2015-2020)
  • Table 21. Multiplex Biomarker Imaging Others , by Region USD Million (2015-2020)
  • Table 22. South America Multiplex Biomarker Imaging, by Country USD Million (2015-2020)
  • Table 23. South America Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 24. South America Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 25. South America Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 26. South America Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 27. Brazil Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 28. Brazil Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 29. Brazil Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 30. Brazil Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 31. Argentina Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 32. Argentina Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 33. Argentina Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 34. Argentina Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 35. Rest of South America Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 36. Rest of South America Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 37. Rest of South America Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 38. Rest of South America Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 39. Asia Pacific Multiplex Biomarker Imaging, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 42. Asia Pacific Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 43. Asia Pacific Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 44. China Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 45. China Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 46. China Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 47. China Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 48. Japan Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 49. Japan Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 50. Japan Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 51. Japan Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 52. India Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 53. India Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 54. India Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 55. India Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 56. South Korea Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 57. South Korea Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 58. South Korea Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 59. South Korea Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 60. Taiwan Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 61. Taiwan Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 62. Taiwan Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 63. Taiwan Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 64. Australia Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 65. Australia Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 66. Australia Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 67. Australia Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 72. Europe Multiplex Biomarker Imaging, by Country USD Million (2015-2020)
  • Table 73. Europe Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 74. Europe Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 75. Europe Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 76. Europe Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 77. Germany Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 78. Germany Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 79. Germany Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 80. Germany Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 81. France Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 82. France Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 83. France Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 84. France Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 85. Italy Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 86. Italy Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 87. Italy Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 88. Italy Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 89. United Kingdom Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 90. United Kingdom Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 91. United Kingdom Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 92. United Kingdom Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 93. Netherlands Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 94. Netherlands Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 95. Netherlands Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 96. Netherlands Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 97. Rest of Europe Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 98. Rest of Europe Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 99. Rest of Europe Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 100. Rest of Europe Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 101. MEA Multiplex Biomarker Imaging, by Country USD Million (2015-2020)
  • Table 102. MEA Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 103. MEA Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 104. MEA Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 105. MEA Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 106. Middle East Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 107. Middle East Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 108. Middle East Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 109. Middle East Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 110. Africa Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 111. Africa Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 112. Africa Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 113. Africa Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 114. North America Multiplex Biomarker Imaging, by Country USD Million (2015-2020)
  • Table 115. North America Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 116. North America Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 117. North America Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 118. North America Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 119. United States Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 120. United States Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 121. United States Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 122. United States Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 123. Canada Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 124. Canada Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 125. Canada Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 126. Canada Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 127. Mexico Multiplex Biomarker Imaging, by Type USD Million (2015-2020)
  • Table 128. Mexico Multiplex Biomarker Imaging, by Application USD Million (2015-2020)
  • Table 129. Mexico Multiplex Biomarker Imaging, by Components USD Million (2015-2020)
  • Table 130. Mexico Multiplex Biomarker Imaging, by End User USD Million (2015-2020)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Multiplex Biomarker Imaging: by Type(USD Million)
  • Table 142. Multiplex Biomarker Imaging Immunohistochemistry (IHC) Assay , by Region USD Million (2021-2026)
  • Table 143. Multiplex Biomarker Imaging Fluorescent In Situ , by Region USD Million (2021-2026)
  • Table 144. Multiplex Biomarker Imaging Hybridization (FISH) Assay , by Region USD Million (2021-2026)
  • Table 145. Multiplex Biomarker Imaging Tissue Microarray (TMA) Assay , by Region USD Million (2021-2026)
  • Table 146. Multiplex Biomarker Imaging: by Application(USD Million)
  • Table 147. Multiplex Biomarker Imaging Oncology Studies , by Region USD Million (2021-2026)
  • Table 148. Multiplex Biomarker Imaging Drug Safety , by Region USD Million (2021-2026)
  • Table 149. Multiplex Biomarker Imaging Genetic Characterization , by Region USD Million (2021-2026)
  • Table 150. Multiplex Biomarker Imaging Others , by Region USD Million (2021-2026)
  • Table 151. Multiplex Biomarker Imaging: by Components(USD Million)
  • Table 152. Multiplex Biomarker Imaging Kits , by Region USD Million (2021-2026)
  • Table 153. Multiplex Biomarker Imaging Instruments , by Region USD Million (2021-2026)
  • Table 154. Multiplex Biomarker Imaging Software , by Region USD Million (2021-2026)
  • Table 155. Multiplex Biomarker Imaging Other , by Region USD Million (2021-2026)
  • Table 156. Multiplex Biomarker Imaging: by End User(USD Million)
  • Table 157. Multiplex Biomarker Imaging Research Institutes , by Region USD Million (2021-2026)
  • Table 158. Multiplex Biomarker Imaging Translational Lab , by Region USD Million (2021-2026)
  • Table 159. Multiplex Biomarker Imaging Pharma & Biopharma Companies , by Region USD Million (2021-2026)
  • Table 160. Multiplex Biomarker Imaging Hospitals , by Region USD Million (2021-2026)
  • Table 161. Multiplex Biomarker Imaging Others , by Region USD Million (2021-2026)
  • Table 162. South America Multiplex Biomarker Imaging, by Country USD Million (2021-2026)
  • Table 163. South America Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 164. South America Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 165. South America Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 166. South America Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 167. Brazil Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 168. Brazil Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 169. Brazil Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 170. Brazil Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 171. Argentina Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 172. Argentina Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 173. Argentina Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 174. Argentina Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 175. Rest of South America Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 176. Rest of South America Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 177. Rest of South America Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 178. Rest of South America Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 179. Asia Pacific Multiplex Biomarker Imaging, by Country USD Million (2021-2026)
  • Table 180. Asia Pacific Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 181. Asia Pacific Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 182. Asia Pacific Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 183. Asia Pacific Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 184. China Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 185. China Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 186. China Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 187. China Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 188. Japan Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 189. Japan Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 190. Japan Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 191. Japan Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 192. India Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 193. India Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 194. India Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 195. India Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 196. South Korea Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 197. South Korea Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 198. South Korea Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 199. South Korea Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 200. Taiwan Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 201. Taiwan Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 202. Taiwan Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 203. Taiwan Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 204. Australia Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 205. Australia Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 206. Australia Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 207. Australia Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 208. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 209. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 210. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 212. Europe Multiplex Biomarker Imaging, by Country USD Million (2021-2026)
  • Table 213. Europe Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 214. Europe Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 215. Europe Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 216. Europe Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 217. Germany Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 218. Germany Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 219. Germany Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 220. Germany Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 221. France Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 222. France Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 223. France Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 224. France Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 225. Italy Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 226. Italy Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 227. Italy Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 228. Italy Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 229. United Kingdom Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 230. United Kingdom Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 231. United Kingdom Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 232. United Kingdom Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 233. Netherlands Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 234. Netherlands Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 235. Netherlands Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 236. Netherlands Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 237. Rest of Europe Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 238. Rest of Europe Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 239. Rest of Europe Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 240. Rest of Europe Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 241. MEA Multiplex Biomarker Imaging, by Country USD Million (2021-2026)
  • Table 242. MEA Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 243. MEA Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 244. MEA Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 245. MEA Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 246. Middle East Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 247. Middle East Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 248. Middle East Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 249. Middle East Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 250. Africa Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 251. Africa Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 252. Africa Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 253. Africa Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 254. North America Multiplex Biomarker Imaging, by Country USD Million (2021-2026)
  • Table 255. North America Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 256. North America Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 257. North America Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 258. North America Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 259. United States Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 260. United States Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 261. United States Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 262. United States Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 263. Canada Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 264. Canada Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 265. Canada Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 266. Canada Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 267. Mexico Multiplex Biomarker Imaging, by Type USD Million (2021-2026)
  • Table 268. Mexico Multiplex Biomarker Imaging, by Application USD Million (2021-2026)
  • Table 269. Mexico Multiplex Biomarker Imaging, by Components USD Million (2021-2026)
  • Table 270. Mexico Multiplex Biomarker Imaging, by End User USD Million (2021-2026)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Multiplex Biomarker Imaging: by Type USD Million (2015-2020)
  • Figure 5. Global Multiplex Biomarker Imaging: by Application USD Million (2015-2020)
  • Figure 6. Global Multiplex Biomarker Imaging: by Components USD Million (2015-2020)
  • Figure 7. Global Multiplex Biomarker Imaging: by End User USD Million (2015-2020)
  • Figure 8. South America Multiplex Biomarker Imaging Share (%), by Country
  • Figure 9. Asia Pacific Multiplex Biomarker Imaging Share (%), by Country
  • Figure 10. Europe Multiplex Biomarker Imaging Share (%), by Country
  • Figure 11. MEA Multiplex Biomarker Imaging Share (%), by Country
  • Figure 12. North America Multiplex Biomarker Imaging Share (%), by Country
  • Figure 13. Global Multiplex Biomarker Imaging share by Players 2020 (%)
  • Figure 14. Global Multiplex Biomarker Imaging share by Players (Top 3) 2020(%)
  • Figure 15. Global Multiplex Biomarker Imaging share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Ultivue Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Ultivue Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Luminex Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 25. BioTek Instruments, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 26. BioTek Instruments, Inc (United States) Revenue: by Geography 2020
  • Figure 27. Akoya Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 28. Akoya Biosciences (United States) Revenue: by Geography 2020
  • Figure 29. BioreclamationIVT. ELEVATING SCIENCE (United States) Revenue, Net Income and Gross profit
  • Figure 30. BioreclamationIVT. ELEVATING SCIENCE (United States) Revenue: by Geography 2020
  • Figure 31. Applied Micro Arrays (United States) Revenue, Net Income and Gross profit
  • Figure 32. Applied Micro Arrays (United States) Revenue: by Geography 2020
  • Figure 33. Pacific Biomarkers (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pacific Biomarkers (United States) Revenue: by Geography 2020
  • Figure 35. PerkinElmer Inc (United States) Revenue, Net Income and Gross profit
  • Figure 36. PerkinElmer Inc (United States) Revenue: by Geography 2020
  • Figure 37. Global Multiplex Biomarker Imaging: by Type USD Million (2021-2026)
  • Figure 38. Global Multiplex Biomarker Imaging: by Application USD Million (2021-2026)
  • Figure 39. Global Multiplex Biomarker Imaging: by Components USD Million (2021-2026)
  • Figure 40. Global Multiplex Biomarker Imaging: by End User USD Million (2021-2026)
  • Figure 41. South America Multiplex Biomarker Imaging Share (%), by Country
  • Figure 42. Asia Pacific Multiplex Biomarker Imaging Share (%), by Country
  • Figure 43. Europe Multiplex Biomarker Imaging Share (%), by Country
  • Figure 44. MEA Multiplex Biomarker Imaging Share (%), by Country
  • Figure 45. North America Multiplex Biomarker Imaging Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Bio-Rad Laboratories, Inc. (United States)
  • Ultivue Inc. (United States)
  • Luminex Corporation (United States)
  • Merck KGaA (Germany)
  • BioTek Instruments, Inc (United States)
  • Akoya Biosciences (United States)
  • BioreclamationIVT. ELEVATING SCIENCE (United States)
  • Applied Micro Arrays (United States)
  • Pacific Biomarkers (United States)
  • PerkinElmer Inc (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation